Roche MDx Sales Grow 7 Percent in 2015 | GenomeWeb

This article has been updated with information from Roche's earnings presentation.

NEW YORK (GenomeWeb) – Roche today reported a 7 percent increase in molecular diagnostics sales for 2015, driven by its molecular and sequencing businesses.

Overall, the Swiss pharmaceutical and diagnostics company reported CHF 48.15 billion ($47.53 billion) in sales for the year, a one percent increase over the CHF 47.46 billion in sales for 2014. On a constant currency basis, sales grew 5 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.